Bradley & Co. Private Wealth Management, LLC - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 59 filers reported holding GALECTIN THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.0%.

Quarter-by-quarter ownership
Bradley & Co. Private Wealth Management, LLC ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,920
+33.3%
1,0000.0%0.00%
+100.0%
Q2 2023$1,440
-31.4%
1,0000.0%0.00%
-50.0%
Q1 2023$2,100
+85.8%
1,0000.0%0.00%
+100.0%
Q4 2022$1,130
-43.5%
1,0000.0%0.00%
-50.0%
Q3 2022$2,000
+100.0%
1,0000.0%0.00%
+100.0%
Q2 2022$1,000
-50.0%
1,0000.0%0.00%
-50.0%
Q1 2022$2,0000.0%1,0000.0%0.00%0.0%
Q4 2021$2,000
-50.0%
1,0000.0%0.00%
-33.3%
Q3 2021$4,000
+33.3%
1,0000.0%0.00%0.0%
Q2 2021$3,000
+50.0%
1,0000.0%0.00%
+50.0%
Q1 2021$2,0001,0000.00%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 184,742$401,0000.10%
Geneos Wealth Management Inc. 511,606$2,261,0000.06%
SHEPHERD KAPLAN KROCHUK, LLC 12,000$26,0000.01%
OCCUDO QUANTITATIVE STRATEGIES LP 18,967$41,0000.01%
Vivaldi Capital Management LP 10,668$45,0000.01%
OSAIC HOLDINGS, INC. 1,221,984$2,651,0000.01%
CENTAURUS FINANCIAL, INC. 15,614$34,0000.00%
WEDBUSH SECURITIES INC 17,998$39,0000.00%
D.A. DAVIDSON & CO. 65,310$142,0000.00%
Virtu Financial LLC 14,683$32,0000.00%
View complete list of GALECTIN THERAPEUTICS INC shareholders